Metronidazole Tablet 200mg Bp/USP/Cp Medicine

• Customization: Available
• Medicine: Oral Preparation
• Transport Package: Carton
• Model NO.: 200mg
• Trademark: SHIMEN
• Origin: Hebei
• HS Code: 3004909099
• Production Capacity: 1000000000

Product Description

Metronidazole Tablet

Product Name: Metronidazole Tablet
Main ingredients: Metronidazole. Chemical name: 2-Methyl-5-nitroimidazole-1-ethanol.
Structural formula: C₆H₉N₃O₃
Mol wt: 171.16
Description: The product is white tablet.
Pharmacology and toxicity
The product is one of potent anaerobicidal Nitro -imidazole derivative agents, which has the effect of inhibiting Ameba protozoon from the redox reaction, and makes nitrogen chain of protozoon rupture. The study shows that Ameba have conformation change within 6~20 hours, and killed within 24 hours after administering the medicine with the concentration 1~2mg/L; Ameba are killed within 72 hours with the concentration 0.2mg/L.
In all the product has potent effect of killing trichomonad, but the exact mechanism is unknown. The product and the metabolites can kill the anaerobic organisms, inhibit bacteria from synthesis of deoxyribonucleic acid, and make influence to the growth and breeding of the bacteria, and lead to the death at the end. Metronidazole may lead to cancer to some animals. 

Shijiazhuang No. 4 Pharmaceutical Co., Ltd., as one of the leading manufacturers in Chinese pharmaceutical industry and a well-known brand, has a business history of seventy years. The company principally specializes in R & D, manufacture and sales of wide types of drugs mainly including intravenous infusion.
The production lines have achieved full automation control and information control in the production process and logistics process and reached international advanced level by integrating the world's leading equipment and technology.
With product quality as its life, the Company always organizes production in strict accordance with GMP requirements, establishes and implements superior service concepts and measures and provides guarantee for the health of the majority of patients at home and abroad with excellent quality products and services.
The Company has a powerful R&D team and made a number of achievements in scientific research and undertaken many major scientific and technological innovation projects and industrialization projects by firmly grasping the pulse of pharmaceutical development, increasing new product development investment and accelerating the pace of technological innovation.
Large volume injection is the key products, tablets, capsules, small volume injection and other forms are manufactured also. Recently API has been put into production and sales. There are more than ten international advanced production lines for the large volume injection, its production scale, technology level, brand influence and economic benefit are on the forefront of domestic counterparts, and it has become one of China's top 100 pharmaceutical industry enterprises and China's top 10 chemical and pharmaceutical industry preparation export-oriented excellent enterprise brands for many consecutive years.
The products are radiated to all provinces, autonomous regions and municipalities in China and also exported to many overseas markets, including more than 80 countries in Asia, Americas, Europe, Oceania, Africa and other continents, and it has become one of the main export enterprises of infusion products.